Lineage Cell Therapeutics, Inc.
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Dec 2011 | 52.28x | $0.09 | $4.69 |
| Dec 2012 | 33.51x | $0.08 | $2.53 |
| Dec 2013 | 45.21x | $0.06 | $2.91 |
| Dec 2014 | 53.34x | $0.06 | $3.01 |
| Dec 2015 | 50.47x | $0.07 | $3.31 |
| Dec 2016 | 56.52x | $0.06 | $3.16 |
| Dec 2017 | 64.34x | $0.03 | $1.88 |
| Dec 2018 | 23.19x | $0.04 | $0.91 |
| Dec 2019 | 37.93x | $0.02 | $0.89 |
| Dec 2020 | 147.56x | $0.01 | $1.76 |
| Dec 2021 | 92.84x | $0.03 | $2.45 |
| Dec 2022 | 13.51x | $0.09 | $1.17 |
| Dec 2023 | 21.04x | $0.05 | $1.09 |
| Dec 2024 | 10.54x | $0.05 | $0.50 |
| Dec 2025 | 25.29x | $0.06 | $1.60 |